000 01397 a2200409 4500
005 20250518094644.0
264 0 _c20210607
008 202106s 0 0 eng d
022 _a1543-8392
024 7 _a10.1021/acs.molpharmaceut.9b01247
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Shuang
245 0 0 _aAnti-HER2 Affibody-Conjugated Photosensitizer for Tumor Targeting Photodynamic Therapy.
_h[electronic resource]
260 _bMolecular pharmaceutics
_c05 2020
300 _a1546-1557 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNeoplasms, Experimental
_xdrug therapy
650 0 4 _aPhotochemotherapy
_xmethods
650 0 4 _aPhotosensitizing Agents
_xtherapeutic use
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aReceptor, ErbB-2
_xanalysis
700 1 _aJin, Yingying
700 1 _aSu, Yao
700 1 _aLi, Wenjing
700 1 _aXing, Yutong
700 1 _aWang, Fengwei
700 1 _aHong, Zhangyong
773 0 _tMolecular pharmaceutics
_gvol. 17
_gno. 5
_gp. 1546-1557
856 4 0 _uhttps://doi.org/10.1021/acs.molpharmaceut.9b01247
_zAvailable from publisher's website
999 _c30835056
_d30835056